Enterobacter aerogenes
Report Name: 2003 Pedi Enterobacter aerogenes
Query Selection Criteria:
Report Start Date: 01/01/2003 (MM/DD/YYYY)
Report End Date: 12/31/2003 (MM/DD/YYYY)
Organism: Enterobacter aerogenes
Drug: Amikacin;Ampicillin;Cefazolin;Cefepime;Cefotaxime;Ceftazidime;Ce
ftriaxone;Ciprofloxacin;Colistin;Gentamicin;Imipenem;Nitrofurantoi
n;Piperacillin;Piperacillin/tazobactam;Tobramycin;Trimeth/sulfa
Breakpoint: NCCLS
Patient Type: Inpatient;Inpatient - ICU;Outpatient
Patient Age: greater than or equal to 0 AND less than or equal to 18
Institution: T84 University of CA at San Francisco - Parnassus
Street-ALL;T84 Mt. Zion Medical Center - Divisedero Street
Trending: None
Dataset: Institution
Chosen Country: United States
Source: TSN Database
Copyright 2004 Focus Technologies, Inc.
Organism Enterobacter aerogenes S S I I R R
Drug Total N % N % N %
Amikacin 10 10 100.0 % 0 0.0 % 0 0.0 %
Ampicillin 10 0 0.0 % 0 0.0 % 10 100.0 %
Cefazolin 10 0 0.0 % 0 0.0 % 10 100.0 %
Cefepime 10 10 100.0 % 0 0.0 % 0 0.0 %
Cefotaxime 10 6 60.0 % 4 40.0 % 0 0.0 %
Ceftazidime 10 6 60.0 % 1 10.0 % 3 30.0 %
Ceftriaxone 10 6 60.0 % 4 40.0 % 0 0.0 %
Ciprofloxacin 10 10 100.0 % 0 0.0 % 0 0.0 %
Gentamicin 10 10 100.0 % 0 0.0 % 0 0.0 %
Imipenem 10 10 100.0 % 0 0.0 % 0 0.0 %
Nitrofurantoin 2 1 50.0 % 0 0.0 % 1 50.0 %
Piperacillin 8 5 62.5 % 3 37.5 % 0 0.0 %
Piperacillin/tazobactam 10 6 60.0 % 4 40.0 % 0 0.0 %
Tobramycin 10 10 100.0 % 0 0.0 % 0 0.0 %
Trimeth/sulfa 10 10 100.0 % 0 0.0 % 0 0.0 %
For agents with >25% of strains tested: